1. Search Result
Search Result
Results for "

DArg-DLys-DTyr-DTyr-Gly-DTrp

" in MedChemExpress (MCE) Product Catalog:

12

Inhibitors & Agonists

12

Peptides

Cat. No. Product Name Target Research Areas Chemical Structure
  • HY-P11807

    ADC Linker Cancer
    DArg-DLys-DTyr-DTyr-Gly-DTrp is a cleavable linker used in the synthesis of antibody-drug conjugates (ADCs) .
    DArg-DLys-DTyr-DTyr-Gly-DTrp
  • HY-P11446

    Transmembrane Glycoprotein Cancer
    AE105 is a 9-mer peptide probe targeting the urokinase-type plasminogen activator receptor (uPAR). AE105 binds tightly to the uPA-binding cavity of uPAR. AE105 can be used for the study of cancer .
    AE105
  • HY-146127A

    Src Others
    Grb2 SH2 domain inhibitor 1 TFA is a conformationally restricted cyclic cell penetrating peptide (CPP) containing d-pro-l-pro motif ring (AF Φ Rpprrfq) (where Φ It is L-naphthylalanine, R is D-arginine, P is D-proline), which is mainly used as a cyclic peptide inhibitor.
    Grb2 SH2 domain inhibitor 1 TFA
  • HY-146127

    MEK Cancer
    Grb2 SH2 domain inhibitor 1 is an inhibitor of the Grb2 SH2 domain with an IC50 of 0.40 μM. Grb2 SH2 domain inhibitor 1 is also a cell-permeable cyclic peptide that can enter the cytosol of mammalian cells. Grb2 SH2 domain inhibitor 1 downregulates the expression level of p-MEK. Grb2 SH2 domain inhibitor 1 can be used in the research of breast cancer .
    Grb2 SH2 domain inhibitor 1
  • HY-P11451

    CXCR Cancer
    Pentixather is a radiolabeled peptide that can target CXCR4. Pentixather can disrupt the interaction between leukemic cells and the bone marrow microenvironment by targeting the CXCR4/CXCL12 signaling axis, reduce the retention of leukemic cells in the protective bone marrow niche, and thereby enhance the sensitivity of leukemic cells to treatment. Pentixather can be used for the study of acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML) .
    Pentixather
  • HY-P10304C

    Fungal Infection
    Cyclo(Pro-dArg) is an inhibitor of chitinase. Cyclo(Pro-dArg) inhibits the cell separation of Saccharomyces cerevisiae but does not affect its growth. Cyclo(Pro-dArg) inhibits the transition of Candida albicans from yeast to filamentous morphology.
    Cyclo(Pro-dArg)
  • HY-P11446A

    Transmembrane Glycoprotein Cancer
    AE105 TFA is a 9-mer peptide probe targeting the urokinase-type plasminogen activator receptor (uPAR). AE105 TFA binds tightly to the uPA-binding cavity of uPAR. AE105 TFA can be used for the study of cancer .
    AE105 TFA
  • HY-P11806

    ADC Linker Cancer
    DLeu-DTyr-Gly-DTrp-Gly-DTyr-DTrp is a cleavable linker used in the synthesis of antibody-drug conjugates (ADCs) .
    DLeu-DTyr-Gly-DTrp-Gly-DTyr-DTrp
  • HY-P11804

    ADC Linker Cancer
    DTyr-Gly-DTyr-Gly is a cleavable linker used in the synthesis of antibody-drug conjugates (ADCs) .
    DTyr-Gly-DTyr-Gly
  • HY-P11805

    ADC Linker Cancer
    Gly-Gly-DTyr-Gly-Gly is a cleavable linker used in the synthesis of antibody-drug conjugates (ADCs) .
    Gly-Gly-DTyr-Gly-Gly
  • HY-P10304D

    Fungal Infection
    Cyclo(Pro-dArg) acetate is a chitinase inhibitor. Cyclo(Pro-dArg) acetate inhibits the cell separation of Saccharomyces cerevisiae but does not affect its growth. Cyclo(Pro-dArg) acetate inhibits the transition of Candida albicans from yeast to filamentous morphology .
    Cyclo(Pro-dArg) acetate
  • HY-P11655

    Somatostatin Receptor Neurological Disease
    NOTA-TATE is a somatostatin receptor 2 (SSTR2) binder. NOTA-TATE binds to SSTR2 to enable targeting of SSTR2-positive tumour cells for PET imaging. NOTA-TATE can be used for the research of neuroendocrine tumours .
    NOTA-TATE

Inquiry Online

Your information is safe with us. * Required Fields.

Salutation

 

Country or Region *

Applicant Name *

 

Organization Name *

Department *

     

Email Address *

 

Product Name *

Cat. No.

 

Requested quantity *

Phone Number *

     

Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent: